An experience at your disposal...

We are a client-driven, results-oriented Contract Research Organization (CRO) delivering high quality clinical trial services in Russia, Ukraine, Eastern Europe and Georgia. Our work focuses on clinical trials for pharmaceuticals, medical devices and nutritional studies, as well as medical device registration in Russia.

Best results are achieved when everyone involved in the process works as an organic team. Knowing that, we always go a step further to become our clients’ ultimate partner in their study, to precisely understand their needs and provide optimal solutions, to use our extensive experience in the region combined with a western approach to customer service and management in order to achieve results that exceed the expectations.

We invite you to consider the services we offer and to contact us to discuss your clinical trial needs.

Company News

Accell will exhibit at BIO International Convention, Washington, DC, June 27-30, 2011. Booth #4208.
Fri, 05/13/2011 - 14:24

Accell will exhibit at BIO International Convention, Washington, DC, June 27-30, 2011. Booth #4208.

Now more than before biotechnology and pharmaceutical companies are searching for ways to optimize their clinical development programs to ensure that clinical studies result in quality data accepted by regulatory agencies and are cost effective. Many companies positively consider Russia and Eastern Europe precisely for the reason of high patient availability translating into increased patient recruitment speed, excellent data quality, cost-effectiveness of clinical programs and data acceptability by FDA and EMEA. ACCELL works with pharmaceutical, biotechnology and CRO clients and we know exactly what our clients are looking for: quality of service, excellence in client relations, high rate of patient recruitment, and cost effectiveness. ACCELL @ BIO International Convention
Welcome new business development team member
Fri, 05/13/2011 - 14:12

Welcome new business development team member

Accell Clinical Research is pleased to welcome Dr. Zagit Gaymalov as a part of our team. Dr. Gaymalov joins us as a Business Development professional with a strong background in pharmaceutical and research industry. He will lead Business Development efforts in North America and serve as a liaison for US and Canadian clients.
Full Profile
New study in patients with metastatic or recurrent squamous cell carcinoma of the head and neck
Fri, 05/13/2011 - 14:09

New study in patients with metastatic or recurrent squamous cell carcinoma of the head and neck

Accell has started a clinical study with 8 sites in Russia in patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck. Recently, the study has been extended to 16 sites.
Pharmaceutical products Functional Foods Medical Devices